BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nguyen TPN, Kumar M, Fedele E, Bonanno G, Bonifacino T. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases. Int J Mol Sci 2022;23:4718. [PMID: 35563107 DOI: 10.3390/ijms23094718] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Almohaimeed HM, Assiri R, Althubaiti EH, Aggad WS, Shaheen S, Shaheen MY, Batarfi MA, Alharbi NA, Alshehri AM, Alkhudhairy BSM. Non-Coding RNAs as Key Players in the Neurodegenerative diseases: Multi-platform Strategies and Approaches for exploring the Genome's Dark Matter. J Chem Neuroanat 2023;:102236. [PMID: 36709005 DOI: 10.1016/j.jchemneu.2023.102236] [Reference Citation Analysis]
2 Elangovan A, Venkatesan D, Selvaraj P, Pasha MY, Babu HWS, Iyer M, Narayanasamy A, Subramaniam MD, Valsala Gopalakrishnan A, Kumar NS, Vellingiri B. miRNA in Parkinson's disease: From pathogenesis to theranostic approaches. Journal Cellular Physiology 2022. [DOI: 10.1002/jcp.30932] [Reference Citation Analysis]
3 Suvarna V, Deshmukh K, Murahari M. miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson's disease. Front Pharmacol 2022;13:1034072. [PMID: 36506536 DOI: 10.3389/fphar.2022.1034072] [Reference Citation Analysis]
4 Tomczyk-socha M, Tomczak W, Turno-kręcicka A. The Importance of MicroRNA Expression in Pseudoexfoliation Syndrome. IJMS 2022;23:13234. [DOI: 10.3390/ijms232113234] [Reference Citation Analysis]
5 Fu R, Tsai C, Liu S, Chiu S, Chen Y, Chiang Y, Kuo Y, Shyu W, Lin S. Neuroprotective Capability of Narcissoside in 6-OHDA-Exposed Parkinson’s Disease Models through Enhancing the MiR200a/Nrf-2/GSH Axis and Mediating MAPK/Akt Associated Signaling Pathway. Antioxidants 2022;11:2089. [DOI: 10.3390/antiox11112089] [Reference Citation Analysis]
6 Glavač D, Mladinić M, Ban J, Mazzone GL, Sámano C, Tomljanović I, Jezernik G, Ravnik-glavač M. The Potential Connection between Molecular Changes and Biomarkers Related to ALS and the Development and Regeneration of CNS. IJMS 2022;23:11360. [DOI: 10.3390/ijms231911360] [Reference Citation Analysis]
7 Yang YL, Lin TK, Huang YH. MiR-29a inhibits MPP + - Induced cell death and inflammation in Parkinson's disease model in vitro by potential targeting of MAVS. Eur J Pharmacol 2022;:175302. [PMID: 36174668 DOI: 10.1016/j.ejphar.2022.175302] [Reference Citation Analysis]